Shamburg News · 8-K filed Nov 12, 2026, 5:20 PM EST

Elite Pharmaceuticals Reports Q2 Fiscal 2027 Revenue of $40.1 Million and Net Income of $17.3 Million

ELTP · ELITE PHARMACEUTICALS INC /NV/

  • Earnings
  • Reg FD disclosure
  • Materiality: high

Elite Pharmaceuticals, Inc. reported results for the second quarter of fiscal 2027 ended September 30, 2026, with consolidated revenues of $40.1 million, up $3.8 million or approximately 10.4% year over year. Income from operations was $9.9 million, an increase of $1.7 million or approximately 21%, and net income attributable to common shareholders was $17.3 million. The company also scheduled a conference call for November 13, 2026 at 11:30 AM EST to discuss the results.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 7.01, 9.01, accession 0001493152-26-051484.

Written from the filing by Shamburg Markets. Figures are as reported by the company.